These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 27813512

  • 1. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.
    Joseph NM, Chen YY, Nasr A, Yeh I, Talevich E, Onodera C, Bastian BC, Rabban JT, Garg K, Zaloudek C, Solomon DA.
    Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of diffuse malignant peritoneal mesothelioma.
    Hung YP, Dong F, Torre M, Crum CP, Bueno R, Chirieac LR.
    Mod Pathol; 2020 Nov; 33(11):2269-2279. PubMed ID: 32504035
    [Abstract] [Full Text] [Related]

  • 3. BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.
    Leblay N, Leprêtre F, Le Stang N, Gautier-Stein A, Villeneuve L, Isaac S, Maillet D, Galateau-Sallé F, Villenet C, Sebda S, Goracci A, Byrnes G, McKay JD, Figeac M, Glehen O, Gilly FN, Foll M, Fernandez-Cuesta L, Brevet M.
    J Thorac Oncol; 2017 Apr; 12(4):724-733. PubMed ID: 28034829
    [Abstract] [Full Text] [Related]

  • 4. BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.
    Alakus H, Yost SE, Woo B, French R, Lin GY, Jepsen K, Frazer KA, Lowy AM, Harismendy O.
    J Transl Med; 2015 Apr 16; 13():122. PubMed ID: 25889843
    [Abstract] [Full Text] [Related]

  • 5. Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models.
    Kukuyan AM, Sementino E, Kadariya Y, Menges CW, Cheung M, Tan Y, Cai KQ, Slifker MJ, Peri S, Klein-Szanto AJ, Rauscher FJ, Testa JR.
    Cancer Res; 2019 Aug 15; 79(16):4113-4123. PubMed ID: 31151962
    [Abstract] [Full Text] [Related]

  • 6. Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
    Chen-Yost HI, Tjota MY, Gao G, Mitchell O, Kindler H, Segal J, Husain AN, Mueller J, Schulte JJ.
    Am J Clin Pathol; 2023 Sep 01; 160(3):238-246. PubMed ID: 37141416
    [Abstract] [Full Text] [Related]

  • 7. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42.
    Stevers M, Rabban JT, Garg K, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, Zaloudek C, Solomon DA.
    Mod Pathol; 2019 Jan 01; 32(1):88-99. PubMed ID: 30171198
    [Abstract] [Full Text] [Related]

  • 8. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.
    Cheung M, Kadariya Y, Pei J, Talarchek J, Facciolo F, Visca P, Righi L, Cozzi I, Testa JR, Ascoli V.
    Cancer Genet; 2015 Oct 01; 208(10):502-7. PubMed ID: 26364129
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.
    Sementino E, Menges CW, Kadariya Y, Peri S, Xu J, Liu Z, Wilkes RG, Cai KQ, Rauscher FJ, Klein-Szanto AJ, Testa JR.
    J Cell Physiol; 2018 Nov 01; 233(11):8952-8961. PubMed ID: 29904909
    [Abstract] [Full Text] [Related]

  • 10. Genomic profiling of multiple primary cancers including synchronous lung adenocarcinoma and bilateral malignant mesotheliomas: Identification of a novel BAP1 germline variant.
    Shinozaki-Ushiku A, Kohsaka S, Kage H, Oda K, Miyagawa K, Nakajima J, Aburatani H, Mano H, Ushiku T.
    Pathol Int; 2020 Oct 01; 70(10):775-780. PubMed ID: 32583627
    [Abstract] [Full Text] [Related]

  • 11. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.
    Brich S, Bozzi F, Perrone F, Tamborini E, Cabras AD, Deraco M, Stacchiotti S, Dagrada GP, Pilotti S.
    Mod Pathol; 2020 Feb 01; 33(2):217-227. PubMed ID: 31570769
    [Abstract] [Full Text] [Related]

  • 12. Genomic landscape of pleural and peritoneal mesothelioma tumours.
    Hiltbrunner S, Fleischmann Z, Sokol ES, Zoche M, Felley-Bosco E, Curioni-Fontecedro A.
    Br J Cancer; 2022 Nov 01; 127(11):1997-2005. PubMed ID: 36138075
    [Abstract] [Full Text] [Related]

  • 13. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
    Hung YP, Dong F, Watkins JC, Nardi V, Bueno R, Dal Cin P, Godleski JJ, Crum CP, Chirieac LR.
    JAMA Oncol; 2018 Feb 01; 4(2):235-238. PubMed ID: 28910456
    [Abstract] [Full Text] [Related]

  • 14. BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
    Cigognetti M, Lonardi S, Fisogni S, Balzarini P, Pellegrini V, Tironi A, Bercich L, Bugatti M, Rossi G, Murer B, Barbareschi M, Giuliani S, Cavazza A, Marchetti G, Vermi W, Facchetti F.
    Mod Pathol; 2015 Aug 01; 28(8):1043-57. PubMed ID: 26022455
    [Abstract] [Full Text] [Related]

  • 15. BAP1 protein is a progression factor in malignant pleural mesothelioma.
    Arzt L, Quehenberger F, Halbwedl I, Mairinger T, Popper HH.
    Pathol Oncol Res; 2014 Jan 01; 20(1):145-51. PubMed ID: 23963927
    [Abstract] [Full Text] [Related]

  • 16. Malignant Mesothelioma and Its Non-Asbestos Causes.
    Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL.
    Arch Pathol Lab Med; 2018 Jun 01; 142(6):753-760. PubMed ID: 29480760
    [Abstract] [Full Text] [Related]

  • 17. Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members.
    Kittaneh M, Berkelhammer C.
    J Transl Med; 2018 Jul 13; 16(1):194. PubMed ID: 30001711
    [Abstract] [Full Text] [Related]

  • 18. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.
    Singhi AD, Krasinskas AM, Choudry HA, Bartlett DL, Pingpank JF, Zeh HJ, Luvison A, Fuhrer K, Bahary N, Seethala RR, Dacic S.
    Mod Pathol; 2016 Jan 13; 29(1):14-24. PubMed ID: 26493618
    [Abstract] [Full Text] [Related]

  • 19. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
    Xu J, Kadariya Y, Cheung M, Pei J, Talarchek J, Sementino E, Tan Y, Menges CW, Cai KQ, Litwin S, Peng H, Karar J, Rauscher FJ, Testa JR.
    Cancer Res; 2014 Aug 15; 74(16):4388-97. PubMed ID: 24928783
    [Abstract] [Full Text] [Related]

  • 20. Malignant Peritoneal Mesothelioma in an Adolescent Male With BAP1 Deletion.
    Taylor S, Carpentieri D, Williams J, Acosta J, Southard R.
    J Pediatr Hematol Oncol; 2015 Jul 15; 37(5):e323-7. PubMed ID: 25222065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.